NEW YORK, June 21 /PRNewswire/ -- World Wide Relics, Inc.
(OTC Bulletin Board: WRLC) ("WWR"), announced today that its
majority ownership has been acquired by China PharmaHub Corp.
("PharmaHub"). PharmaHub is a global pharmaceutical HUB
specializing in the identification, development and marketing of
pharmaceutical and healthcare products.
In conjunction with the purchase, Mr. John Amand and Mr. E.
Todd Owens have resigned as officers and directors of the
board. Mr. Richard Lui and Ms.
Monica Ding have been appointed to
the board of directors and Mr. Lui will assume the role of Chairman
and Chief Executive Officer of WWR effective immediately.
About World Wide Relics:
World Wide Relics, Inc. produces and markets historical costumes
and reenactment clothing lines. The company sells its products to
the enthusiasts and collectors on e-stores, such as Ebay.com. World
Wide Relics, Inc. was founded in 2005 and is based in New York, New York. As of January 17, 2007, World Wide Relics, Inc.
operates as a subsidiary of Electric Car Company, Inc.
About PharmaHub:
China PharmaHub Corp. is engaged in the business of licensing,
development and commercialization of pharmaceutical and healthcare
products and technologies between Chinese pharmaceutical companies
and other pharmaceutical companies located worldwide with initial
emphasis in the United States and
Europe (with a goal of eventually
becoming a global pharmaceutical "HUB"). PharmaHub brings a unique
wealth of resources to assist scientists and companies in bringing
their ideas to reality. PharmaHub's corporate headquarters are
located in California, with
offices in Boston and China.
Forward-Looking Statements
This press release, together with other statements and
information publicly disseminated by the Company, contains certain
forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. The Company
intends such forward-looking statements to be covered by the safe
harbor provisions for forward-looking statements contained in the
Private Securities Litigation Reform Act of 1995 and includes this
statement for purposes of complying with these safe harbor
provisions. Forward-looking statements, which are based on certain
assumptions and describe the Company's future plans, strategies and
expectations, are generally identifiable by use of the words
"believe," "expect," "intend," "anticipate," "estimate," "project"
or similar expressions. You should not rely on forward-looking
statements since they involve known and unknown risks,
uncertainties and other factors that are, in some cases, beyond the
Company's control and which could materially affect actual results,
performances or achievements. Factors that may cause actual results
to differ materially from current expectations include the risk
factors discussed in the Company's filing with the Securities
Exchange Commission. Accordingly, there is no assurance that the
Company's expectations will be realized. Except as otherwise
required by the federal securities laws, the Company disclaims any
obligation or undertaking to publicly release any updates or
revisions to any forward-looking statement contained herein (or
elsewhere) to reflect any change in the Company's expectations with
regard thereto or any change in events, conditions or circumstances
on which any such statement is based.
SOURCE China PharmaHub Corp.
